News

“There are many stressors in cardiovascular medicine, including an aging cardiovascular patient population and workforce, and a decrease in cardiologists entering the field because of insufficient fellowship positions despite the rising...

The Iocyte AMI-3 trial is a randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of FDY-5301 in reducing cardiovascular death and heart failure events in anterior STEMI patients undergoing PCI.

Passive heat exposure was enough to increase myocardial blood flow in all participants, regardless of age and health status, creating significant stress on the heart. The authors observed asymptomatic heat-induced myocardial ischemia in some...

“Some clinicians are already recommending beetroot juice to men and women with high blood pressure,” Jocelyn Delgado Spicuzza said. “By providing a safe and effective way to improve blood vessel function, beets could help maintain...

New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien...

“This document provides for the first time a standardization on nomenclature for quantitative parameters derived from CCTA,” said Hector Garcia-Garcia, MD, PhD. “It marks a turning point in reporting of CCTA as it focuses on actual...

“This study again shows the immediate need for investigating sugar alcohols and artificial sweeteners, especially as they continue to be recommended in combatting conditions like obesity or diabetes,” said Stanley Hazen, MD, PhD.

An analysis of data from the PARTNER Trials through five-year follow-up of more than 1,300 low- and intermediate-risk SAPIEN 3 valve patients demonstrated excellent clinical outcomes and valve durability irrespective of the patient’s annulus...

"The ORFAN study is an expanding global registry which will include long-term clinical and outcome data for 250,000 patients from around the world, and we are very pleased to publish these initial results,” said Keith Channon, MD.

PARIS – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, announced positive results from its first-in-human CLOT OUT clinical trial evaluating the safety and performance of its Clotild® Smart...